HRMY
Harmony Biosciences Holdings, Inc. · Healthcare · Biotechnology
动量输入(同类管理人):
持有人广度 +7.1% ·
股份流向 -11.5% ·
净新建仓位 +6.7%
· 公式
持有人分散化:持有人数增多,合计持仓比例缩小。
所有持股数据:仅限已追踪的 13F 管理人,普通股持仓,报告期 Q1 2025
| 季度 | 持有人 | Δ | 股份 | 报告持仓市值 | 新增 | 清仓 |
|---|---|---|---|---|---|---|
| Q3 2026 | 1 | 0 | 21.01K | $831,838 | n/a | −2 |
| Q2 2026 | 111 | +5 | 37.63M | $1.37B | +12 | −8 |
| Q1 2026 | 110 | -3 | 39.20M | $1.10B | +5 | −9 |
| Q4 2025 | 114 | +1 | 39.01M | $1.46B | +2 | n/a |
| Q3 2025 | 20 | +1 | 24.69M | $680.58M | +2 | −2 |
| Q2 2025 | 17 | -1 | 23.07M | $729.13M | +1 | −2 |
| Q1 2025 | 15 | +1 | 6.74M | $223.55M | +1 | n/a |
| Q4 2024 | 14 | -1 | 7.61M | $261.77M | n/a | −1 |
| Q3 2024 | 14 | +1 | 3.56M | $142.57M | +1 | n/a |
| Q2 2024 | 13 | n/a | 3.50M | $105.70M | n/a | n/a |
| # | 管理人 | 股份 | Δ股份 | 价值 | 其权重 | 持有 | ||
|---|---|---|---|---|---|---|---|---|
| 1 | State Street Global Advisors ✦ (被动) | 1.58M | -0.1% | $52.41M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 2 | Geode Capital Management ✦ (被动) | 965.75K | +7.0% | $32.06M | 0.0% | ▲ Add | 4 | SEC ↗ ×2 |
| 3 | Marshall Wace ✦ | 887.54K | -4.5% | $29.46M | 0.0% | ▼ Trim | 4 | SEC ↗ ×2 |
| 4 | Citadel Advisors ✦ | 862.41K | -37.0% | $28.62M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 5 | Renaissance Technologies ✦ | 840.37K | +47.8% | $27.89M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 6 | Arrowstreet Capital ✦ | 398.41K | +34.3% | $13.22M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 7 | Two Sigma Investments ✦ | 345.81K | +25.5% | $11.48M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 8 | D. E. Shaw & Co. ✦ | 319.70K | -33.5% | $10.61M | 0.0% | ▼ Trim | 4 | SEC ↗ ×2 |
| 9 | Adage Capital Partners ✦ | 168.00K | -66.4% | $5.58M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 10 | AQR Capital Management ✦ | 166.34K | +4.7% | $5.52M | 0.0% | ▲ Add | 4 | SEC ↗ ×5 |
| 11 | Millennium Management ✦ | 78.49K | +1139.4% | $2.61M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 12 | Norges Bank ✦ (被动) | 54.05K | -88.5% | $1.79M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 13 | T. Rowe Price ✦ | 29.84K | +50.8% | $991,000 | 0.0% | ▲ Add | 4 | SEC ↗ |
| 14 | Gotham Asset Management ✦ | 23.16K | -54.1% | $768,780 | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 15 | Wellington Management ✦ | 16.36K | 新增 | $542,889 | 0.0% | New | 1 | SEC ↗ ×4 |
"持仓权重"指该仓位占该管理人13F申报股票组合市值的比例,即持仓信心指标。✦ = 精选管理人。
新增买入方
| Wellington Management | $542,889 | 0.0% |
已清仓
| 本季度无被追踪的退出仓位。 |
全市场背景: 涵盖所有13F申报机构(SEC结构化数据, Q1 2026): 306 持有人, 54.70M 股份, $1.38B 已申报. 这是与上方被追踪全域数据不同的较早期间,两者从不混用。
持有该证券的受追踪机构最常同时持有的其他证券:基于共同持有计数,而非基本面关联。
公开市场买入 (P)
在我们的覆盖窗口内无内部人士公开市场买入记录。
公开市场卖出 (S)
Officer · 35.85K 股 · $1.54M
Officer · 800 股 · $34,400
Officer · 1.80K 股 · $77,426
Officer · 22.95K 股 · $989,350
Officer · 1.00K 股 · $42,795
Officer · 4.50K 股 · $190,114
Officer · 5.50K 股 · $230,911
授予、行权及税务代扣代缴在本平台均不计入买入或卖出。 方法论